STRATIFIED APPROACH TO PREVENTION OF NO-REFLOW PHENOMENON DURING ENDOVASCULAR TREATMENT OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION
E.YU. BESSONOV,
A.N. SHISHKEVICH,
S.S. MIKHAYLOV,
V.N. KRAVCHUK
Affiliations
E.YU. BESSONOV
Department of Endovascular Methods of Diagnosis and Treatment, Alexander Hospital, St. Petersburg, Russian Federation
A.N. SHISHKEVICH
21st Department of Advanced Training Surgery, Military Medical Academy named after C.M. Kirov, St. Petersburg, Russian Federation. 3Department of Cardiovascular Surgery, North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russian
S.S. MIKHAYLOV
21st Department of Advanced Training Surgery, Military Medical Academy named after C.M. Kirov, St. Petersburg, Russian Federation. 3Department of Cardiovascular Surgery, North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russian
V.N. KRAVCHUK
21st Department of Advanced Training Surgery, Military Medical Academy named after C.M. Kirov, St. Petersburg, Russian Federation. 3Department of Cardiovascular Surgery, North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russian
Objective: To develop and test an algorithm for no-reflow phenomenon (NRP) prevention during endovascular treatment of patients with ST-elevation myocardial infarction (STEMI) Methods: A prospective single-center randomized study included 100 patients diagnosed with STEMI who underwent coronary artery stenting. Group 1 included 50 patients who were operated using an algorithm for the NRP prevention, while Group 2 included 50 patients who underwent routine transluminal balloon angioplasty and stenting of the coronary arteries. The NRP risk was assessed using the predictive model by Wang JW et al Results: Both groups were comparable in terms of anamnestic and clinical data, biochemical and instrumental examination results. High NRP risk was determined in 36% of Group 1 patients and 40% of Group 2 patients. NRP developed significantly less often in Group 1 patients compared to Group 2 (14% vs. 36%, p=0.01). Worsening of Killip class of acute heart failure was found significantly less common in Group 1 patients compared to Group 2 (2% versus 16%, p=0.03) Conclusion: The proposed algorithm for NRP prevention increased the effectiveness of treatment for STEMI